Vanda Pharmaceuticals Inc. (VNDA) — Research Summary as of 2026-10-31

Note on source reliability: Several sources below are flagged in their original form as AI-generated or as proprietary "calibrated estimates" and are subject to error ([3], [1]). Figures that corroborate across independent outlets (SEC-derived data, MarketBeat, Yahoo Finance, PRNewswire) are treated as higher-confidence. I do not verify, re-derive, or report back the earlier point-in-time snapshot data (e.g., the ~$229.18M market cap noted for 2026-10-30), which was provided as background only.

Recent Catalysts (roughly July–October 2026)